Stacy Ann Coen's Insider Trades & SAST Disclosures
Stacy Ann Coen's most recent trade in FibroBiologics Inc was a trade of 5,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Aug. 27, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Stacy Ann Coen.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| FibroBiologics Inc | Stacy Ann Coen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Aug 2024 | 5,000 | 5,000 | - | - | Stock Option (Right to Buy) | |
| Immunogen, Inc. | Stacy Coen Ann | SVP & CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Dec 2023 | 30,000 | 303,465 | - | - | Stock Option (Right to Buy) | |
| Immunogen, Inc. | Coen Stacy Ann | SVP & CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.32 per share. | 29 Dec 2023 | 30,000 | 63,140 (0%) | 0% | 5.3 | 159,600 | Common Stock |
| Immunogen, Inc. | Coen Ann Stacy | SVP & CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 16.01 per share. | 29 Dec 2023 | 367 | 63,507 (0%) | 0% | 16.0 | 5,876 | Common Stock |
| Immunogen, Inc. | Coen Ann Stacy | SVP & CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 29.20 per share. | 30 Nov 2023 | 3,826 | 33,140 (0%) | 0% | 29.2 | 111,719 | Common Stock |
| Immunogen, Inc. | Stacy Ann Coen | SVP & CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 4.05 per share. | 30 Jun 2023 | 3,792 | 10,960 (0%) | 0% | 4.1 | 15,358 | Common Stock |
| Immunogen, Inc. | Stacy Ann Coen | SVP & CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2023 | 245,900 | 245,900 | - | - | Stock Option (right to buy) | |
| Immunogen, Inc. | Stacy Ann Coen | SVP & CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2023 | 41,000 | 41,000 | - | - | Restricted Stock Unit | |
| Immunogen, Inc. | Stacy Ann Coen | SVP & CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 3.82 per share. | 30 Jun 2022 | 3,342 | 7,168 (0%) | 0% | 3.8 | 12,783 | Common Stock |
| Immunogen, Inc. | Stacy Ann Coen | SVP & CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2022 | 60,000 | 90,000 | - | - | Stock Option (Right to Buy) | |
| Immunogen, Inc. | Stacy Ann Coen | SVP & CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2022 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Immunogen, Inc. | Stacy Ann Coen | SVP & Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 333,465 | 333,465 | - | - | Common Stock (right to buy) | |
| Immunogen, Inc. | Stacy Ann Coen | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 5.52 per share. | 30 Jun 2021 | 2,330 | 2,330 (0%) | 0% | 5.5 | 12,862 | Common Stock |
| Immunogen, Inc. | Stacy Ann Coen | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2021 | 185,016 | 185,016 | - | - | Common Stock (right to buy) | |
| Immunogen, Inc. | Stacy Ann Coen | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2020 | 260,000 | 260,000 | - | - | Common Stock (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges